Detalles de la búsqueda
1.
FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease.
Nature
; 584(7822): 619-623, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32581359
2.
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries.
Rheumatology (Oxford)
; 63(3): 751-764, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37314967
3.
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.
J Rheumatol
; 51(4): 378-389, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38224992
4.
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries.
Ann Rheum Dis
; 82(6): 820-828, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36813538
5.
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Ann Rheum Dis
; 82(10): 1286-1295, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37423647
6.
Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogen.
Rheumatology (Oxford)
; 62(2): 886-893, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35460235
7.
Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries.
Rheumatology (Oxford)
; 62(2): 647-658, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35723604
8.
Second and third TNF inhibitors in European patients with axial spondyloarthritis: Effectiveness and impact of the reason for switching.
Rheumatology (Oxford)
; 2023 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37738257
9.
Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment.
J Hepatol
; 76(1): 86-92, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34487751
10.
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries.
Ann Rheum Dis
; 81(6): 789-797, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35318218
11.
Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark.
Rheumatology (Oxford)
; 61(9): 3711-3722, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864891
12.
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration.
Rheumatology (Oxford)
; 61(11): 4286-4296, 2022 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35139178
13.
The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries.
Rheumatology (Oxford)
; 61(9): 3647-3656, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34940795
14.
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis.
Rheumatology (Oxford)
; 61(12): 4741-4751, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35323903
15.
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response.
Rheumatology (Oxford)
; 61(9): 3799-3807, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34940840
16.
Resolution of Th/Tc17-driven inflammation during anti-TNFα treatment of rheumatoid arthritis reveals a unique immune biomarker profiling pattern.
Scand J Immunol
; 95(1): e13116, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35213743
17.
Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis.
Clin Exp Rheumatol
; 40(7): 1393-1402, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34796837
18.
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration.
Ann Rheum Dis
; 80(11): 1410-1418, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34083206
19.
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study.
Rheumatology (Oxford)
; 60(8): 3656-3668, 2021 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33401297
20.
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis.
Rheumatology (Oxford)
; 60(8): 3635-3645, 2021 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33367900